Educational Problems, Family Relations, Medication Adherence, Mental Disorder, Psychiatric Disorder, Psychiatric Hospitalization, Relapse, Schizophrenia
Conditions
Keywords
schizophrenia, psychoeducation program, family caregiver, relapse, medication adherence, burden
Brief summary
The involvement of family members is crucial and improves the prognosis of psychiatric patients and reinforces therapeutic adherence and reduces the frequency of relapses. For schizophrenia, the scientific literature clearly shows that it's in the interest of the patient to offer to his family a psychoeducational program. Therapeutic education programs are now part of the recommendations of good clinical practice and in the French health through the law n ° 2009-879 of July 21, 2009 on the reform of the hospital and relating to patients, health and territories.
Detailed description
Objectives We conducted a randomized study in two groups to evaluate the impact of a psychoeducational program for caregivers. Methods 60 patients with a DSM-V diagnosis of schizophrenia and their families' caregivers are recruited. Families' caregivers are randomly assigned to receive either a 6 session psychoeducation program, or no psychoeducation. Baseline evaluations: Patients: symptomatology (PANSS), medication adherence (MARS); Families' Caregivers: Quality of Life (S-CGQoL), Burden (Zarit), knowledge of disease (KAST), therapeutic alliance (4PAS caregivers), depression (CES-D), medication adherence (CRS).
Interventions
BEHAVIORALPsychoeducation
6 session psychoeducation program with the family caregiver of schizophrenics patients.
Sponsors
Centre Hospitalier Charles Perrens, Bordeaux
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
SINGLE (Outcomes Assessor)
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
* Diagnosis of schizophrenia, based on ICD-10 (F20 to F29) * Receive in-patient treatment at hospital (or medical center linked to Charles Perrens Hospital) * Be the caregiver or parent of the patient * Patient informed of the diagnosis of his disease
Exclusion criteria
* Mental retardation or other diagnoses that could affect the ability to answer questionnaires, after the acute schizophrenia psychosis is controlled * Suicidal ideation * Non-comprehension of the French language
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Relapse | baseline (pre-treatment) to six months post-baseline | Reduction in the rate of relapse (hospitalization) in patients whose family participated in the psychoeducation group compared to patients without psychoeducation. |
| Medication adherence (caregiver perception) | baseline (pre-treatment) to six months post-baseline. | Change from baseline (pre-treatment) to 6 months post-baseline in caregiver-report of medication adherence using respectively the Compliance Rating Scale. |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Quality of Life | baseline (pre-treatment) to six months post-baseline | Change from baseline (pre-treatment) to 6 months post-baseline in patient-report of quality of life using the Schizophrenia Caregiver Quality of Life questionnaire. |
| Burden | baseline (pre-treatment) to six months post-baseline | Change from baseline (pre-treatment) at 6 months post-baseline in family-report of burden using the Zarit Questionnaire. |
Countries
France
Outcome results
None listed